灵康药业：关于控股股东部分股份解除质押的公告

Core Viewpoint - Lingkang Pharmaceutical announced the release of share pledges by its controlling shareholder, Lingkang Holdings Group, which holds a significant portion of the company's total shares [2] Group 1 - Lingkang Holdings directly and indirectly holds 339.6528 million unrestricted circulating shares, accounting for 47.09% of the company's total share capital [2] - The shares being released from pledge amount to 49.6596 million, representing 14.62% of the total shares held by Lingkang Holdings and 6.89% of the company's total share capital [2]